News

2 Minute Medicine12m
Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
The use of dapagliflozin in patients with metabolic dysfunction-associated steatohepatitis (MASH) resulted in a higher ...
Medical Dialogues17h
Parexel successfully completes CRO registration with CDSCO
Mumbai: Parexel, a clinical research organisation (CRO) providing the full range of Phase I to IV clinical development ...